Patents by Inventor Malcolm A. Martin

Malcolm A. Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240076361
    Abstract: Disclosed herein an anti-pT217 Tau antibody or a pT217 Tau-binding fragment thereof.
    Type: Application
    Filed: February 17, 2022
    Publication date: March 7, 2024
    Inventors: Sonia CIEZAREK, Malcolm Ian ROBERTS, James Martin STADDON, Takashi OBARA, Yohei MUKAI, Lal Kishan AGARWALA
  • Patent number: 6065901
    Abstract: A system for use in preventing a flow of gas from a gas-containing region (20) to an adjacent region (22) and/or for collecting or dispersing gas at the interface between the regions, comprising a composite barrier (10) installed so as to separate the two regions (20, 22), the barrier (10) comprising a gas-impermeable layer (11) and a gas-permeable membrane (12) interconnected so as to define an interspace (16) between them and arranged with the permeable layer (12) facing the region containing gas (20) to be dispersed or collected. A method is also described comprising the steps of connecting an aperture (36) or aperture of the barrier communicating with the interspace (16) thereof to pumping means (37) which, in operation, act to pump gas into or out from the interspace (16) by creating a pressure differential across the permeable membrane such as to cause gas to flow therethrough across a major proportion of its surface area.
    Type: Grant
    Filed: April 2, 1997
    Date of Patent: May 23, 2000
    Assignee: Prestige Air Technology Limited
    Inventors: Richard Stevens, Paul Nichols, Malcolm Martin
  • Patent number: 4931393
    Abstract: The present invention is related to providing a non-infectious molecular clone of a mutant HIV and HIV proteins useful as immunogens and reagents for diagnostic kit.
    Type: Grant
    Filed: September 14, 1987
    Date of Patent: June 5, 1990
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Malcolm A. Martin, Ronald Willey
  • Patent number: 4752565
    Abstract: Leu-3.sup.- cells surviving infection with the AIDS retrovirus can be induced with IUdR to express infectious virus. A cellular clone (8E5), isolated by limiting dilution of a mass culture of survivor cells, was found to contain a single, integrated, defective provirus that was consitutively expressed. Although IUdR treatment of 8E5 cells failed to induce infectious virus, cocultivation with Leu-3.sup.+ generated the characteristic syncytia associated with acute AIDS retrovirus infention. The single integrated copy of proviral DNA directs the synthesis of all major viral structural proteins except p64 and p34 as monitored by immunoblotting. Diagnostic reagents and kits in accordance with the present invention are also described.
    Type: Grant
    Filed: April 7, 1986
    Date of Patent: June 21, 1988
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Thomas M. Folks, Douglas M. Powell, Malcolm A. Martin
  • Patent number: D991081
    Type: Grant
    Filed: May 24, 2021
    Date of Patent: July 4, 2023
    Inventor: Malcolm Martin